1-9 of 9
Teresa Kimlinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mechanism of Action of a Novel c-Met Inhibitor MK2461 In Multiple Myeloma

Vijay G. Ramakrishnan, PhD, Teresa Kimlinger, Jessica Haug, Timothy Halling, Linda Wellik, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 4078.
https://doi.org/10.1182/blood.V116.21.4078.4078
Published: 2010
Journal Articles

Investigational Agent MLN2238/MLN9708, a Specific, Orally Available, Small Molecule Proteasome Inhibitor, Shows Promising In Vitro Activity Against Multiple Myeloma Cell Lines

Giada Bianchi, MD, Vijay G. Ramakrishnan, PhD, Teresa Kimlinger, Jessica Haug, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 3014.
https://doi.org/10.1182/blood.V116.21.3014.3014
Published: 2010
Journal Articles

Significant In Vitro Activity of a Novel Inhibitor of Apoptosis (IAP) Inhibitor LC161 In Multiple Myeloma

Jessica Haug, Vijay G. Ramakrishnan, PhD, Teresa Kimlinger, Timothy Halling, Linda Wellik, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2010) 116 (21): 2998.
https://doi.org/10.1182/blood.V116.21.2998.2998
Published: 2010
Journal Articles

Significant in-Vitro Activity of a Novel JAK2 Inhibitor in Multiple Myeloma Associated with Preferential Cytotoxicity for CD45+ Myeloma Cells.

Vijay Ramakrishnan, PhD, Jessica Haug, Teresa Kimlinger, Timothy Halling, Linda Wellik, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD
Journal: Blood
Blood (2009) 114 (22): 2848.
https://doi.org/10.1182/blood.V114.22.2848.2848
Published: 2009
Journal Articles

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma

Yazan Alsayed, Hai Ngo, Judith Runnels, Xavier Leleu, Ujjal K. Singha, Costas M. Pitsillides, Joel A. Spencer, Teresa Kimlinger, Joanna M. Ghobrial, Xiaoying Jia, Ganwei Lu, Michael Timm, Ashok Kumar, Daniel Côté, Israel Veilleux, Karen E. Hedin, G. David Roodman, Thomas E. Witzig, Andrew L. Kung, Teru Hideshima, Kenneth C. Anderson, Charles P. Lin, Irene M. Ghobrial
Journal: Blood
Blood (2006) 109 (7): 2708–2717.
https://doi.org/10.1182/blood-2006-07-035857
Published: 2006
Journal Articles

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vivo Activity in a Mouse Model of Myeloma.

Michael Timm, Linda Wellik, Teresa Kimlinger, Jessica Haug, Michael Kline, Ph.D, S. Vincent Rajkumar, MD, Philip Greipp, MD, Shaji Kumar, MD
Journal: Blood
Blood (2006) 108 (11): 3487.
https://doi.org/10.1182/blood.V108.11.3487.3487
Published: 2006
Journal Articles

A Phase II Trial of Gleevec™ in Patients with Refractory/Relapsed Myeloma.

Angela Dispenzieri, MD, Thomas E. Witzig, MD, Martha Q. Lacy, MD, Susan M. Geyer, PhD, Teresa Kimlinger, S. Vincent Rajkumar, MD, Philip R. Greipp, MD, Rafael Fonseca, MD, John A. Lust, MD, PhD, Steven R. Zeldenrust, MD, PhD, Susazanne R. Hayman, MD, Morie A. Gertz, MD
Journal: Blood
Blood (2004) 104 (11): 2420.
https://doi.org/10.1182/blood.V104.11.2420.2420
Published: 2004
Journal Articles

Plasma Cell Folate Receptor Overexpression Differentiates Multiple Myeloma from Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma.

Patricia Greipp, D.O., Greg Cascino, Teresa Kimlinger, Vincent Rajkumar, M.D., Franklyn G. Prendergast, Ph.D., M.D., Rafael Fonseca, M.D., P. Leif Bergsagel, M.D., Philip S. Low, Ph.D., Philip R. Greipp, M.D.
Journal: Blood
Blood (2004) 104 (11): 3649.
https://doi.org/10.1182/blood.V104.11.3649.3649
Published: 2004
Journal Articles

Clinical and Biological Correlates of CD45 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma.

Shaji Kumar, MD, S. Vincent Rajkumar, MD, Teresa Kimlinger, Philip R. Greipp, MD, Thomas E. Witzig, MD
Journal: Blood
Blood (2004) 104 (11): 3362.
https://doi.org/10.1182/blood.V104.11.3362.3362
Published: 2004